A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination
NCT: NCT06168942 · SUSPENDED
Brief Summary
The purpose of this study is to compare the safety and effectiveness of Laminar Left Atrial Appendage Closure (LAAC) device as compared to the commercially available LAAC devices in participants with non-valvular atrial fibrillation (NVAF) to reduce the risk of stroke (blocked blood vessel or bleeding in brain) and systemic embolism (blockage in a blood vessel harming vital organs).
Frequently Asked Questions
What is A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination?
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination is a clinical trial registered under NCT06168942. Current status: SUSPENDED.
What is the status of NCT06168942?
The current status of NCT06168942 (A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination) is: SUSPENDED.
When did A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination start?
A Pivotal Investigational Device Exemption Study on Laminar Left Atrial Appendage Elimination started on 2024-02-19.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.